User menu

Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients

Primary tabs
Add to cart
Print
Copyright (Sherpa/Romeo)
Authors :
Document type : Communication à un colloque (Conference Paper) – Poster
Access type : Accès libre
Publication date : 2010
Language : Anglais
Conference : "9th Meeting of The European Association of NeuroOncology", Maastricht(Netherlands) (du 16/09/2010 au 19/09/2010)
Journal information : "Neuro-Oncology" - Vol. 12, no. Suppl. 3, p. 46-47 (2010)
Peer reviewed : yes
issn : 1522-8517
e-issn : 1523-5866
Publisher : Oxford University Press ((United States) Cary)
Publication status : Publié
Affiliations : UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
UCL - (SLuc) Unité d'oncologie médicale
Links :
Bibliographic reference Renard, Laurette ; Clement, P. M. ; Hammouch, Fatima ; Boterberg, T. ; Verschaeve, V. ; et. al. Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients.9th Meeting of The European Association of NeuroOncology (Maastricht(Netherlands), du 16/09/2010 au 19/09/2010). In: Neuro-Oncology, Vol. 12, no. Suppl. 3, p. 46-47 (2010)
Permanent URL http://hdl.handle.net/2078.1/58558